Related Experiment Video
Updated: Jan 10, 2026

Visualization of Replisome Encounters with an Antigen Tagged Blocking Lesion
Published on: July 27, 2021
The Fanconi anemia pathway repairs colibactin-induced DNA interstrand cross-links
Maria Altshuller1, Xu He1, Elliot J MacKrell1
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Abstract:
Colibactin is a secondary metabolite produced by bacteria present in the human gut and is implicated in the development of colorectal cancer. This genotoxin alkylates deoxyadenosines on opposite strands of host cell DNA to produce DNA interstrand cross-links. While cells have evolved multiple mechanisms to resolve ("unhook") interstrand cross-links, little is known about which of these pathways promote resistance to colibactin. Here, we use Xenopus egg extracts to investigate replication-coupled repair of colibactin-induced interstrand cross-links. We show that replication fork stalling at a colibactin-induced interstrand cross-link activates the Fanconi anemia interstrand cross-link repair pathway, which unhooks the interstrand cross-link through nucleolytic incisions. These incisions generate a DNA double-strand break intermediate in one sister chromatid, which can be repaired by homologous recombination, and a monoadduct ("interstrand cross-link remnant") in the other. Translesion synthesis past the colibactin-induced interstrand cross-link remnant depends on Pol η and the Pol κ-REV1-Pol ζ polymerase complex and introduces predominantly T>A point mutations at the sites of colibactin alkylation. Taken together, our work provides a molecular framework for understanding how cells tolerate a naturally occurring and clinically relevant interstrand cross-link.
Insights
Colibactin, a gut bacteria toxin, causes DNA damage linked to colorectal cancer. This study reveals how cells repair this damage, involving the Fanconi anemia pathway and specific polymerases, leading to mutations.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Colibactin is a genotoxin produced by gut bacteria, linked to colorectal cancer development.
- It forms DNA interstrand cross-links (ICLs) by alkylating deoxyadenosines on opposite DNA strands.
- Cellular mechanisms for resolving ICLs exist, but their role in colibactin resistance is unclear.
Purpose of the Study:
- To investigate the replication-coupled repair of colibactin-induced ICLs.
- To identify the cellular pathways involved in tolerating colibactin DNA damage.
Main Methods:
- Utilized Xenopus egg extracts for in vitro studies.
- Analyzed replication fork stalling and DNA repair pathway activation.
- Investigated the roles of specific DNA polymerases in translesion synthesis.
Main Results:
- Replication fork stalling at colibactin ICLs activates the Fanconi anemia (FA) pathway.
- The FA pathway unhooks ICLs via nucleolytic incisions, creating DNA double-strand breaks and monoadducts.
- Translesion synthesis (TLS) by Pol η and the Pol κ-REV1-Pol ζ complex repairs the monoadduct, causing T>A mutations.
Conclusions:
- Established a molecular framework for understanding cellular tolerance to colibactin-induced ICLs.
- Identified key repair pathways and TLS polymerases involved in processing this genotoxin.
- Provides insights into the mechanisms underlying colibactin's role in colorectal carcinogenesis.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Base Excision Repair
The first step of...
Base Excision Repair
Long-patch Base Excision Repair
Nucleotide Excision Repair

